GL1X · GenesisL1 explorer

Research workbench

Crystal structure of a hpiv haemagglutinin-neuraminidase-inhibitor complex

Analyse Crystal structure of a hpiv haemagglutinin-neuraminidase-inhibitor complex in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5KV9
Type
protein
Length
430 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hemagglutinin-neuraminidase
EC
3.2.1.18
UniProt
G8G134
Ligands
I57, NAG, CA
Pockets
6 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 5% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BHemagglutinin-neuraminidase (EC 3.2.1.18)protein4305% helix, 45% strandG8G134

Ligands and binding sites

  • I57 · 2,6-anhydro-3,4,5-trideoxy-5-[(2-methylpropanoyl) amino]-4-(4-phenyl-1H-1,2,3-triazol-1-yl)-D-glycero-D-galacto-non-2-en onic acid · ligand · chains B
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 3 copies · chains B
  • CA · Calcium ion · metal · chains B
  • EDO · 1,2-ethanediol · additive · 3 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13920.660.8041I57
21500.570.8228empty
3880.390.7719empty
4670.350.7716empty
5680.330.7617EDO

Modifications

Observed in the structure: 7 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 5KV9 · Crystal structure of a hPIV haemagglutinin-neuraminidase-inhibitor complex · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.